Indiana Marijuana Legalization Efforts: Timeline, Bills, and Outlook

Executive Summary

Indiana remains one of the most restrictive states in the nation for cannabis policy, with no legal framework for medical or adult-use marijuana as of May 2026. Despite growing momentum in neighboring states and evolving federal policy, the Hoosier State has consistently rejected legalization efforts through legislative inaction and gubernatorial opposition. Recent developments show a state lawmaker drafting a new legalization bill while Indiana regulators await final federal rescheduling action from the Drug Enforcement Administration, creating a potential inflection point for reform advocates. The state's conservative legislative landscape, combined with law enforcement resistance and limited public polling data showing divided opinion, has kept Indiana among the handful of states maintaining complete prohibition even as federal policy shifts toward reclassification of cannabis from Schedule I to Schedule III under the Controlled Substances Act. The economic opportunity cost grows annually, with Illinois collecting over $1.5 billion in adult-use cannabis tax revenue since 2020 while Indiana loses potential tax dollars and sees residents cross state lines for legal purchases.

Why Indiana's Cannabis Policy Matters

Indiana's prohibition stance affects 6.8 million residents, thousands of potential patients, and billions in foregone economic activity. The state sits surrounded by jurisdictions with more permissive policies—Illinois legalized adult-use sales in 2020, Michigan did the same in 2018, and Ohio voters approved adult-use legalization in 2023. This geographic isolation creates unique pressures on Indiana policymakers as tax revenue flows to neighboring states and Hoosier residents face arrest for possession of a substance increasingly normalized across the Midwest. The patient impact proves particularly acute. Indiana residents with qualifying conditions such as epilepsy, chronic pain, PTSD, and cancer lack legal access to medical cannabis products available to patients in 38 other states. Advocates estimate tens of thousands of Hoosiers could benefit from medical marijuana programs, with particular emphasis on veterans, pediatric epilepsy patients, and individuals with opioid use disorder seeking alternative pain management. From an economic perspective, the Indiana Fiscal Policy Institute estimated in 2024 that a regulated adult-use market could generate $172-$310 million annually in state tax revenue depending on tax structure and market maturity. The state's agricultural sector, particularly struggling tobacco farmers in southern counties, represents a potential beneficiary of hemp and cannabis cultivation opportunities. Multi-state operators have identified Indiana as a priority expansion market, with several MSOs maintaining government affairs offices in Indianapolis in anticipation of eventual reform. Law enforcement resources currently dedicated to cannabis enforcement represent another stakeholder consideration. Indiana State Police reported 18,743 marijuana-related arrests in 2025, with possession charges accounting for 82% of cases. Criminal justice reform advocates argue these enforcement priorities disproportionately impact communities of color and divert resources from violent crime investigation.

Background and History of Indiana Cannabis Policy

Indiana's path to prohibition began in 1913, making it one of the earliest states to criminalize cannabis possession and use. The state legislature passed the Indiana Pharmacy Act that year, which included cannabis among controlled substances requiring prescription. This early prohibition predated federal action by decades and established Indiana's pattern of conservative drug policy.

The Controlled Substances Era (1970s-1990s)

When Congress passed the Controlled Substances Act in 1970, classifying marijuana as a Schedule I substance under 21 U.S.C. § 812, Indiana aligned its state statutes accordingly. The Indiana Code Title 35, Article 48 established criminal penalties for possession, cultivation, and distribution that remained largely unchanged for three decades. Possession of any amount became a misdemeanor carrying up to one year incarceration and a $5,000 fine, while cultivation or sale triggered felony charges. The 1980s war on drugs intensified enforcement in Indiana. State police expanded drug task forces, and the legislature enhanced penalties for distribution near schools and public housing. Governor Robert Orr signed legislation in 1987 creating mandatory minimum sentences for repeat marijuana offenses, a framework that persisted until partial reform in 2014.

Decriminalization Debates and CBD Carve-Outs (2000s-2018)

Indiana's first significant cannabis policy shift came not through legalization but through limited decriminalization. In 2014, the legislature reduced simple possession of less than 30 grams from a Class A misdemeanor to a Class B misdemeanor, lowering maximum jail time from one year to 180 days. This modest reform reflected growing recognition that incarceration for small amounts proved costly and ineffective. The 2018 federal Farm Bill's hemp provisions created unexpected momentum in Indiana. The legislation removed hemp—defined as cannabis containing less than 0.3% delta-9 THC—from Schedule I, creating a legal pathway for CBD products. Indiana Governor Eric Holcomb signed Senate Enrolled Act 516 in 2019, establishing a state hemp program under the Indiana State Department of Agriculture. This marked the first time since 1913 that any cannabis cultivation became legal in Indiana, albeit with strict THC limitations. The CBD carve-out created confusion and unintended consequences. Retailers began selling CBD products statewide, and law enforcement struggled to distinguish legal hemp from illegal marijuana without laboratory testing. The Indiana State Police Crime Laboratory reported a backlog of over 3,000 samples awaiting THC testing by late 2019, leading prosecutors to dismiss hundreds of low-level possession cases.

Medical Marijuana Bills and Legislative Failures (2019-2023)

Between 2019 and 2023, Indiana lawmakers introduced at least 11 separate medical marijuana bills, none advancing beyond committee hearings. The most prominent effort came in 2022 when State Representative Jake Teshka filed House Bill 1547, proposing a comprehensive medical cannabis program with 19 qualifying conditions, licensed dispensaries, and a 7% excise tax. The bill attracted bipartisan co-sponsors but died in the House Public Health Committee without a vote. Governor Holcomb consistently opposed these efforts, stating in a 2021 press conference that he would veto any legalization bill reaching his desk while marijuana remained federally illegal. This gubernatorial opposition proved decisive, as legislative leaders declined to advance bills lacking executive support. The 2023 legislative session saw renewed momentum when Senator Greg Taylor introduced Senate Bill 305, a medical-only framework modeled on Ohio's program. The bill included provisions for cultivation licenses, processor permits, and retail dispensaries, with a proposed 5% excise tax dedicated to addiction treatment programs. Public hearings drew hundreds of supporters, including parents of epileptic children and military veterans, but the Senate Corrections and Criminal Law Committee voted 5-4 against advancement in March 2023.

Federal Rescheduling and State Response (2024-2026)

The landscape shifted in 2024 when the DEA published a Notice of Proposed Rulemaking to reclassify marijuana from Schedule I to Schedule III under 21 U.S.C. § 811. This federal action, following a Department of Health and Human Services recommendation, triggered new discussions in Indiana. The proposed rescheduling acknowledged cannabis's accepted medical use and lower abuse potential compared to Schedule I substances, undermining a key argument used by Indiana prohibition advocates. Indiana Attorney General Todd Rokita submitted formal comments opposing the rescheduling in July 2024, arguing that the state's law enforcement interests and public health concerns warranted maintaining Schedule I status. The Indiana Prosecuting Attorneys Council and Indiana Sheriffs' Association filed supporting comments, while the Indiana State Medical Association took no official position. As of May 2026, the DEA has not finalized the rescheduling rule, with administrative law judge hearings and public comment periods extending the timeline. Indiana regulators, particularly within the Alcohol and Tobacco Commission and State Department of Health, have begun preliminary discussions about potential regulatory frameworks should federal rescheduling occur, according to sources familiar with internal deliberations. These conversations remain informal, with no official policy proposals released.

Key Players in Indiana's Legalization Debate

Indiana General Assembly

The Indiana legislature's Republican supermajorities in both chambers have controlled cannabis policy discussions. House Speaker Todd Huston and Senate President Pro Tempore Rodric Bray have declined to prioritize marijuana legislation, citing constituent concerns and law enforcement input. However, individual members have emerged as reform advocates, including Senator Greg Taylor (D-Indianapolis), who has filed medical marijuana bills in three consecutive sessions, and Representative Jake Teshka (R-North Webster), whose 2022 bill represented the most comprehensive Republican-sponsored proposal to date. The unnamed lawmaker currently drafting a legalization bill in May 2026, according to the triggering news report, represents the latest legislative effort. Without public bill text or sponsor identification, the proposal's prospects remain uncertain, though the timing coincides with anticipated federal rescheduling action.

Governor's Office

Governor Eric Holcomb's opposition defined Indiana cannabis policy from 2017 through his final term ending in January 2025. His successor, who took office in 2025, has not publicly articulated a comprehensive cannabis position, though campaign statements suggested openness to medical marijuana if federal rescheduling occurred. The governor's veto power remains decisive—Indiana's legislature has overridden only two gubernatorial vetoes since 2005, making executive support functionally necessary for legalization.

Indiana Alcohol and Tobacco Commission

The ATC would likely assume regulatory authority over any legal cannabis market, given its existing oversight of controlled retail substances. Commission Chairman David Cook stated in a 2024 interview that the agency has studied regulatory frameworks in Illinois, Michigan, and Ohio to prepare for potential Indiana legalization, though no formal rulemaking has begun. The ATC's experience with alcohol licensing and compliance enforcement positions it as the probable lead agency, though some proposals have suggested creating a separate Cannabis Control Board.

Law Enforcement Opposition

The Indiana Sheriffs' Association and Indiana State Police have consistently opposed legalization efforts. ISP Superintendent Doug Carter testified against Senate Bill 305 in 2023, citing concerns about impaired driving, youth access, and black market persistence. The Indiana Prosecuting Attorneys Council has argued that legalization would complicate drug trafficking prosecutions and create workplace safety issues. These law enforcement voices carry substantial weight with rural and suburban legislators representing conservative districts.

Medical and Patient Advocacy Groups

Hoosier Veterans for Medical Cannabis, founded in 2018, has organized the most visible advocacy campaigns, with veteran members testifying at legislative hearings about cannabis's role in PTSD and chronic pain management. The Indiana chapter of NORML coordinates grassroots lobbying, while newer organizations like Hoosiers for Medical Marijuana focus on patient stories and economic arguments. These groups lack the financial resources of national cannabis industry players but provide authentic constituent voices that resonate with some legislators.

Multi-State Operators and Industry

National MSOs including Cresco Labs, Curaleaf, and Verano have maintained government affairs presence in Indiana for several years, anticipating market entry opportunities. Illinois-based cultivators and processors view Indiana as a natural expansion market given proximity and population density. The Marijuana Policy Project and National Cannabis Industry Association have provided technical assistance to Indiana advocacy groups and funded limited polling, though direct industry lobbying has remained relatively quiet compared to other states.

Legal and Regulatory Framework

Indiana Code Title 35, Article 48 establishes criminal penalties for marijuana possession, cultivation, and distribution that remain among the nation's strictest. Possession of any amount constitutes a Class B misdemeanor under IC 35-48-4-11, punishable by up to 180 days incarceration and a $1,000 fine for first offenses. Possession of more than 30 grams elevates to a Class A misdemeanor with up to one year jail time. Cultivation of any amount triggers felony charges under IC 35-48-4-10, with Level 6 felony classification carrying 6 months to 2.5 years imprisonment. Distribution and dealing charges scale based on quantity. Dealing less than 30 grams constitutes a Level 6 felony, while amounts exceeding 10 pounds trigger Level 5 felony charges with 1-6 year sentences. Enhancements apply for sales near schools, parks, or public housing, and for transactions involving minors. These statutory provisions contain no medical necessity defense and no decriminalization threshold—any possession remains criminal. Indiana's paraphernalia statute, IC 35-48-4-8.3, criminalizes possession of pipes, bongs, rolling papers, and other cannabis-related items as Class C misdemeanors. This broad language has survived constitutional challenges, with the Indiana Court of Appeals upholding convictions in State v. Klingler (2019) and related cases. The state's hemp program, established under IC 15-15-13, creates the only legal cannabis cultivation pathway. The Indiana State Department of Agriculture issues hemp grower licenses and processor permits for plants containing less than 0.3% delta-9 THC. As of 2025, Indiana had 467 licensed hemp growers cultivating approximately 3,200 acres, primarily for CBD extraction. The program requires testing at ISO-certified laboratories and mandates destruction of non-compliant crops. Federal law intersects through the Controlled Substances Act's Schedule I classification of marijuana under 21 U.S.C. § 812, which remains in effect pending DEA rescheduling. This federal prohibition prevents banks from serving cannabis businesses under the Bank Secrecy Act, creates tax complications under 26 U.S.C. § 280E disallowing business expense deductions, and exposes participants to federal prosecution despite state legalization elsewhere. Indiana officials have cited federal illegality as justification for maintaining state prohibition, though this argument weakens if DEA finalizes Schedule III rescheduling. The proposed federal rescheduling to Schedule III would not legalize marijuana but would acknowledge accepted medical use and reduce criminal penalties under federal law. It would eliminate 280E tax burdens for cannabis businesses and potentially ease banking restrictions, but would not mandate state-level legalization. Indiana could maintain prohibition even after federal rescheduling, as states retain authority to impose stricter controls on controlled substances.

State-by-State Context: Indiana's Regional Isolation

Indiana's prohibition stance creates a Midwest anomaly, with all bordering states having enacted more permissive cannabis policies.

Illinois

Illinois legalized adult-use cannabis effective January 1, 2020, through the Cannabis Regulation and Tax Act. The state allows possession of up to 30 grams for residents, operates 110 licensed dispensaries as of 2026, and has collected over $1.5 billion in cannabis tax revenue since program launch. Illinois residents can purchase products at dispensaries near the Indiana border in cities like Danville, Munster, and Chicago suburbs, creating convenient access for Hoosiers willing to cross state lines. Illinois law prohibits non-residents from transporting cannabis across state lines, but enforcement proves difficult.

Michigan

Michigan voters approved adult-use legalization through Proposal 1 in November 2018, with sales beginning December 2019. The state permits possession of up to 2.5 ounces and home cultivation of up to 12 plants. Michigan's market has matured rapidly, with over 1,000 licensed retailers and wholesale prices dropping below $1,000 per pound in 2025. Michigan cities near Indiana, including Niles and New Buffalo, have attracted Hoosier customers, though the longer drive compared to Illinois limits cross-border traffic.

Ohio

Ohio voters approved Issue 2 in November 2023, legalizing adult-use possession and sales. The Division of Cannabis Control began issuing retail licenses in 2024, with over 200 dispensaries operational by 2026. Ohio's medical program, launched in 2019, established regulatory infrastructure that facilitated adult-use implementation. Ohio allows possession of up to 2.5 ounces and home cultivation of six plants. The state's eastern border with Indiana creates additional access points for Hoosiers in cities like Richmond and Fort Wayne.

Kentucky

Kentucky enacted medical cannabis legislation in 2023, with the program scheduled to launch dispensary sales in 2025. The state permits possession by qualified patients with conditions including cancer, chronic pain, PTSD, and epilepsy. Kentucky's program does not allow home cultivation and limits possession to a 30-day supply as determined by physicians. While more restrictive than neighboring adult-use states, Kentucky's medical framework still provides broader access than Indiana's complete prohibition. This regional context creates competitive pressure on Indiana policymakers. Border counties lose retail sales tax revenue, and residents face legal risks transporting cannabis purchased legally in neighboring states back to Indiana. Law enforcement resources focus on interdiction rather than local cultivation or distribution, as most cannabis in Indiana originates from legal-state purchases or black market sources supplied from permissive jurisdictions.

Market and Business Implications

Indiana's prohibition costs the state an estimated $200-$300 million annually in foregone tax revenue while neighboring states capture Hoosier consumer spending. Economic modeling by the Indiana University Public Policy Institute in 2025 projected that a mature adult-use market could generate $650-$900 million in annual retail sales, supporting 8,000-12,000 jobs in cultivation, processing, retail, and ancillary services. The state's agricultural sector presents particular opportunity. Indiana ranks fifth nationally in corn and soybean production, with established farming infrastructure and expertise. Tobacco farmers in southern Indiana counties including Dubois, Pike, and Warrick have seen acreage decline 78% since 2000, creating demand for alternative crops. Cannabis cultivation could utilize existing barn infrastructure and provide higher per-acre returns than traditional row crops—Illinois cultivators report wholesale prices of $1,200-$1,800 per pound even after recent price compression, compared to corn revenues of approximately $600 per acre. Multi-state operators have identified Indianapolis as a top-20 market for potential expansion. The metropolitan area's 2.1 million population, median household income of $61,000, and proximity to Illinois and Michigan markets make it attractive for retail investment. MSOs including Cresco Labs and Green Thumb Industries have filed trademark applications for Indiana-specific branding, signaling preparation for eventual market entry. The 280E tax burden under 26 U.S.C. § 280E currently prevents cannabis businesses from deducting ordinary business expenses on federal returns, creating effective tax rates exceeding 70% for plant-touching operations. Federal rescheduling to Schedule III would eliminate this burden, improving unit economics for cultivators and retailers. Indiana-based businesses would benefit from this federal change if state legalization occurred, though the state could impose its own tax structure independent of federal treatment. Banking access remains constrained by federal prohibition. Indiana-chartered banks and credit unions generally refuse accounts for cannabis businesses due to Bank Secrecy Act compliance concerns and FDIC guidance, forcing operators in legal states to use cash-intensive operations or out-of-state banking relationships. Federal rescheduling may ease but not eliminate these restrictions, as marijuana would remain controlled under Schedule III. Real estate implications include potential conversion of vacant retail space in Indiana cities to dispensaries, cultivation facility development in industrial and agricultural zones, and increased property values near retail locations. Illinois and Michigan data show dispensaries generate foot traffic benefiting adjacent businesses, though some communities have imposed zoning restrictions limiting locations near schools and residential areas.

What Experts and Stakeholders Say

Indiana University law professor Robert Fischman, who specializes in drug policy, has stated that Indiana's prohibition increasingly conflicts with federal policy evolution and regional norms. According to Fischman's 2025 analysis, the state's enforcement priorities create legal uncertainty for hemp businesses and CBD retailers while failing to prevent cannabis use among residents who simply cross state lines for legal purchases. The Indiana State Medical Association has not taken an official position on legalization but published a 2024 white paper acknowledging cannabis's therapeutic potential for specific conditions including chemotherapy-induced nausea, chronic pain, and epilepsy. The ISMA called for additional research and recommended that any Indiana medical program include physician oversight, quality testing requirements, and restrictions on smoking as a delivery method. Law enforcement perspectives remain divided. While state-level organizations oppose legalization, some local sheriffs have questioned enforcement priorities. Johnson County Sheriff Duane Burgess stated in a 2024 interview that his department's resources would be better spent on methamphetamine and fentanyl enforcement rather than marijuana possession cases, though he stopped short of endorsing legalization. Economic development officials in border communities have expressed frustration with revenue loss to neighboring states. The Greater Lafayette Commerce president noted in 2025 testimony that Tippecanoe County residents spend an estimated $18-$24 million annually at Illinois dispensaries, representing lost sales tax revenue and economic activity that could support local businesses and jobs. Patient advocacy groups emphasize medical necessity. Heather Douglass, founder of Hoosier Veterans for Medical Cannabis, has described cannabis as essential for managing her PTSD symptoms after military service, stating that she faces criminal risk for using a medicine legally available to veterans in 38 other states. Her organization has documented over 400 Indiana veteran testimonials supporting medical access. National policy experts view Indiana as a laggard state likely to legalize eventually due to regional pressure and federal policy evolution. The Marijuana Policy Project's Indiana director has indicated that the organization sees medical legalization as achievable within 2-3 years if federal rescheduling occurs, with adult-use following 3-5 years later based on patterns in conservative states like Montana and South Dakota.

What's Next: Decision Points and Scenarios

Indiana's cannabis policy trajectory depends on three key variables: federal DEA rescheduling timing, the 2026 legislative session outcomes, and the current governor's position evolution. The DEA rescheduling process represents the most immediate catalyst. If the agency finalizes Schedule III classification in mid-to-late 2026, Indiana regulators would face pressure to reconsider prohibition given federal acknowledgment of medical use. The Alcohol and Tobacco Commission has indicated it would need 12-18 months to develop comprehensive regulations if directed to establish a legal framework, suggesting that even with 2027 legislative authorization, dispensary sales would not begin until 2028 at earliest. The unnamed lawmaker's bill drafting effort mentioned in May 2026 reporting could surface during the 2027 legislative session beginning in January. Indiana's legislative calendar runs January through April, with bill filing deadlines in mid-January. If the proposal includes only medical provisions with limited qualifying conditions, it may attract broader support than previous comprehensive adult-use bills. A medical-only framework modeled on Ohio or Kentucky could pass if the governor signals openness and law enforcement opposition softens. Scenarios for the next 24 months include: **Scenario 1: Federal rescheduling + medical legalization (40% probability)** — DEA finalizes Schedule III classification by late 2026, Indiana legislature passes medical-only bill in 2027 session, governor signs with implementation beginning 2028. This path mirrors conservative-state patterns in Louisiana and Mississippi. **Scenario 2: Continued prohibition (35% probability)** — Legislative leadership declines to advance bills despite federal rescheduling, citing law enforcement concerns and constituent opposition. Indiana remains prohibition state through 2028, joining Idaho and Nebraska as holdouts. **Scenario 3: Ballot initiative campaign (15% probability)** — Reform advocates pursue constitutional amendment through citizen initiative, though Indiana's initiative process requires legislative approval of ballot questions, making this path difficult without legislative support. **Scenario 4: Adult-use legalization (10% probability)** — Comprehensive adult-use bill passes in 2027 or 2028 session following overwhelming public support shift and business community pressure. This scenario requires significant political change and appears unlikely in near term. Key dates to monitor include the DEA's final rescheduling decision (expected summer-fall 2026), the 2027 Indiana legislative session (January-April 2027), and the 2028 gubernatorial election cycle, which could elevate cannabis policy as a campaign issue if prohibition persists while all neighboring states maintain legal markets.

Further Reading and Primary Sources

• Indiana Code Title 35, Article 48 (Criminal Law and Procedure - Offenses Involving Controlled Substances): https://iga.in.gov/legislative/laws/2024/ic/titles/035
• Indiana State Department of Agriculture Hemp Program: https://www.in.gov/isda/divisions/plant-industries/hemp/
• DEA Notice of Proposed Rulemaking - Marijuana Rescheduling (2024): https://www.federalregister.gov/
• 21 U.S.C. § 812 - Controlled Substances Act Schedules: https://www.govinfo.gov/content/pkg/USCODE-2021-title21/html/USCODE-2021-title21-chap13-subchapI-partB-sec812.htm
• Indiana General Assembly Bill Tracking System: https://iga.in.gov/
• Illinois Department of Financial and Professional Regulation - Adult Use Cannabis: https://idfpr.illinois.gov/profs/adultusecan.html
• Michigan Cannabis Regulatory Agency: https://www.michigan.gov/cra
• Ohio Division of Cannabis Control: https://cannabis.ohio.gov/
• Indiana Fiscal Policy Institute Economic Impact Studies: https://www.indianafiscal.org/
• Hoosier Veterans for Medical Cannabis: https://www.facebook.com/HoosierVeteransForMedicalCannabis/
• Indiana NORML: https://www.indiananorml.org/
• 26 U.S.C. § 280E - Tax Code Provisions Affecting Cannabis Businesses: https://www.govinfo.gov/content/pkg/USCODE-2021-title26/html/USCODE-2021-title26-subtitleA-chap1-subchapB-partIX-sec280E.htm